CRISPR Therapeutics AG
CRSP
$41.86
$3.298.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.55% | -1.64% | -3.30% | -5.05% | 24.47% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.22% | -24.74% | -6.17% | -23.58% | 45.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.59% | -0.35% | -3.31% | -5.15% | 11.09% |
|
|
|||||
| Total Current Assets | -3.59% | -0.35% | -3.31% | -5.15% | 11.09% |
| Net Property, Plant & Equipment | -2.83% | -2.55% | -2.31% | -2.32% | -2.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -87.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.27% | -0.23% | 2.81% | 27.66% | 53.94% |
| Total Assets | -3.39% | -0.62% | -3.58% | -4.07% | 9.39% |
|
|
|||||
| Total Accounts Payable | -11.18% | -5.58% | 64.81% | -42.59% | -56.84% |
| Total Accrued Expenses | -28.22% | 10.84% | -8.95% | -62.34% | 154.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.26% | 2.40% | 2.63% | 2.87% | 2.35% |
| Total Finance Division Other Current Liabilities | 269.97% | -24.86% | -65.33% | -9.37% | 383.38% |
| Total Other Current Liabilities | 269.97% | -24.86% | -65.33% | -9.37% | 383.38% |
| Total Current Liabilities | 36.07% | -2.26% | -29.74% | 7.42% | 9.37% |
|
|
|||||
| Total Current Liabilities | 36.07% | -2.26% | -29.74% | 7.42% | 9.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.21% | -2.02% | -1.95% | -1.86% | -1.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.79% | -1.46% | -1.41% | -5.40% | 14.60% |
| Total Liabilities | 8.71% | -2.06% | -11.82% | 1.08% | 2.40% |
|
|
|||||
| Common Stock & APIC | 0.93% | 1.18% | 0.97% | 0.77% | 11.15% |
| Retained Earnings | -9.96% | -2.81% | -6.92% | -11.32% | -11.66% |
| Treasury Stock & Other | 129.08% | -83.07% | 457.12% | -82.22% | -187.20% |
| Total Common Equity | -5.33% | -0.39% | -2.08% | -4.94% | 10.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.33% | -0.39% | -2.08% | -4.94% | 10.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.33% | -0.39% | -2.08% | -4.94% | 10.68% |
|
|
|||||